What's new in soft tissue and bone pathology 2022-updates from the WHO classification 5th edition.

IF 1.7 Q3 PATHOLOGY

Journal of Pathology and Translational Medicine Pub Date : 2022-11-01 Epub Date: 2022-11-15 DOI:10.4132/jptm.2022.10.18

Erica Y Kao, Jose G Mantilla

引用次数: 0

Abstract

The 2020 release of the WHO Classification of Soft Tissue and Bone Tumors, 5th edition, contains several changes driven by new knowledge in the field. These include reclassification of some entities, refinement of risk classification systems, and the inclusion of novel disease processes, many of which are driven by recurrent gene fusions. The most notable changes are described here.

Abstract Image

查看原文本刊更多论文

《软组织和骨骼病理学2022》的新内容——更新自世卫组织分类第5版。

2020年发布的《世卫组织软组织和骨肿瘤分类》第5版包含了由该领域新知识推动的若干变化。这些措施包括对某些实体进行重新分类，改进风险分类系统，并纳入新的疾病过程，其中许多是由复发性基因融合驱动的。这里描述了最显著的变化。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Pathology and Translational Medicine PATHOLOGY-

CiteScore

5.00

自引率

4.20%

发文量

审稿时长

14 weeks

期刊介绍： The Journal of Pathology and Translational Medicine is an open venue for the rapid publication of major achievements in various fields of pathology, cytopathology, and biomedical and translational research. The Journal aims to share new insights into the molecular and cellular mechanisms of human diseases and to report major advances in both experimental and clinical medicine, with a particular emphasis on translational research. The investigations of human cells and tissues using high-dimensional biology techniques such as genomics and proteomics will be given a high priority. Articles on stem cell biology are also welcome. The categories of manuscript include original articles, review and perspective articles, case studies, brief case reports, and letters to the editor.